Systems pharmacology identifies drug targets for Stargardt disease–associated retinal degeneration

Abstract excerpt

A systems pharmacological approach that capitalizes on the characterization of intracellular signaling networks can transform our understanding of human diseases and lead to therapy development. Here, we applied this strategy to identify pharmacological targets for the treatment of Stargardt disease, a severe juvenile form of macular degeneration. Diverse GPCRs have previously been implicated in neuronal cell...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Photoreceptor and optogenetics research
• Share to Retinal Development and Disorders
• Share to Retinal Diseases and Treatments